Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Summary 
David M. Mott is an American businessperson who founded MedImmune Ventures, Inc. and who has been at the head of 18 different companies.

He occupies the position of Chairman of Mersana Therapeutics, Inc., Chairman at Epizyme, Inc., Chairman for Ardelyx, Inc., Chairman for Complexa, Inc., Chairman for Cydan II, Inc., Chairman of Cydan LLC (a subsidiary of Cydan II, Inc.), Chairman of Adaptimmune Therapeutics Plc, Chairman of Imara, Inc. and Chairman at Vtesse, Inc.

He is also on the board of 5 other companies.

In the past Mr. Mott was Chairman for Zyngenia, Inc., Chairman for Sagimet Biosciences, Inc., Executive Vice President of AstraZeneca Plc Vice Chairman, President & Chief Executive Officer at MedImmune LLC, President & Chief Executive Officer for MedImmune Ltd. and President for MedImmune Ventures, Inc. (which are all subsidiaries of AstraZeneca Plc), General Partner for New Enterprise Associates LLC, General Partner at NEA Management Co. LLC, Chairman for Conceptis Technologies, Inc., Chairman of Tesaro, Inc., Chairman-Supervisory Board of Prosensa Holding NV, Chairman of Adaptimmune Ltd., Vice President-Health Care Investment Banking at Smith Barney Harris Upham & Co., Inc. and VP-Health Care Investment Banking Group at Harris Upham & Co, Inc.

He received an undergraduate degree from Dartmouth College.


Current positions of David M. Mott 
NameTitle Since
Novavax, Inc.
(Biotechnology & Medical Research)
Independent Director 2020
Mersana Therapeutics, Inc.
(Biotechnology & Medical Research)
Chairman 2015
Epizyme, Inc.
(Biotechnology & Medical Research)
Chairman 2016
Adaptimmune Therapeutics plc
(Biotechnology & Medical Research)
Chairman 2017
Ardelyx, Inc.
(Biotechnology & Medical Research)
Chairman 2014
IMARA Inc.
(Biotechnology & Medical Research)
Chairman 2016
Cydan II, Inc. Chairman -
Cydan LLC Chairman -
Vtesse, Inc. Chairman -
Biotechnology Innovation Organization Director -
Complexa, Inc. Chairman -
NEA 14 GP Ltd. Director -
XTuit Pharmaceuticals, Inc. Director -
Biohealth Innovation, Inc. Director -


Holdings of David M. Mott 
NameEquities%Valuation
Novavax, Inc. (NVAX)
(Biotechnology & Medical Research)
64,9610.088%9,589,543 USD
Mersana Therapeutics, Inc. (MRSN)
(Biotechnology & Medical Research)
548,1940.79%7,850,138 USD
Ardelyx, Inc. (ARDX)
(Biotechnology & Medical Research)
417,2840.42%2,983,581 USD
Epizyme, Inc. (EPZM)
(Biotechnology & Medical Research)
268,6460.26%2,210,957 USD
Adaptimmune Therapeutics Plc00.0000%0 USD
IMARA Inc. (IMRA)
(Biotechnology & Medical Research)
00.0000%0 USD


David M. Mott: Personal Network 
Most Read News 
07/12ELON MUSK : Musk tells SolarCity trial that Tesla would 'die' if he wasn't CEO
RE
07/15JAMIE DIMON : Analysis-JPMorgan hoards cash as Dimon expects rates to rise
RE
07/13RICHARD BRANSON : Virgin Galactic acknowledges Branson's pre-launch bike ride never happened
RE
07/20JEFF BEZOS : billionaire Bezos has successful suborbital jaunt
RE
07/13ELON MUSK : Musk defends timing of Tesla's $2.6 billion deal for SolarCity
RE
07/26JEFF BEZOS : Bezos-backed plant food firm NotCo joins unicorn club after latest funding
RE
07/26MICHAEL KLEIN : EV maker Lucid rises in Nasdaq debut after merger with Klein-backed SPAC
RE
07/13BRUNELLO CUCINELLI : Italian luxury group Cucinelli raises 2021 sales forecast again
RE
07/22RYAN COHEN : Flush from Reddit rally, GameStop plots store revival
RE
07/18ALEXANDER NOVAK : Novak says Russia to raise oil output in H2
RE
More news


© 2021 People and Ownership :   
David M. Mott : Connections